Month: July 2019

One Hot Stock
TradersPro Alerts

Greenlight Capital Re, Ltd. (GLRE) Buy Target $9.27 – Sell Target $10.93

Trade Setup Buy Target $9.27 Sell Target $10.93 Trailing Stop 20% Greenlight Capital Re, Ltd., through its subsidiaries, operates as a property and casualty reinsurer worldwide. The company offers various property reinsurance products and services, including automobile physical damage; personal lines, such as homeowners’ insurance; and commercial lines. It also provides casualty reinsurance products and […]

Read More
Crude Oil
Energy Sector
Fibonacci Retracement
Fundamental Analysis
Oil
Shale Oil
Technical Analysis
Value Investing
Value Stocks

Is CLR really the big bargain that it seems to be?

While the rest of the market has been pushing to a new set of all-time highs  – as of the end of last week, the S&P 500 was up nearly 19% year-to-date – the energy sector has been struggling lately. As measured by the S&P 500 Energy Sector SPDR ETF (XLE), the sector is down […]

Read More
Stock Picks
Tech Stocks
Technical Analysis

Why One Trader Says This Tech Stock Is One Investors “Have To Own”

This tech stock has been surging higher, and one technician says it has got more upside ahead.

Read More
Breaking News
Fibonacci Retracement
Fundamental Analysis
Risk
Semiconductor
Tech Industry
Technical Analysis
Technology
Value Investing
Value Stocks

Jim Cramer just called MRVL “the #1 5G stock.” Why that doesn’t make it a good deal for you

If you pay attention to the stock market, you inevitably become familiar with some of the personalities that take up space on market media to talk about it. On CNBC, for example, Jim Cramer is an ever-present commentator. Not only does he host his own “Mad Money” show in the afternoons on the network, you’ll […]

Read More
Biotech
One Hot Stock
TradersPro Alerts

BioTime, Inc. (BTX) Buy Target $1.22 – Sell Target $1.41

Buy Target $1.22 Sell Target $1.41 Trailing Stop 20% BioTime, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally. The company’s lead product candidates include OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa multicenter trial for […]

Read More
Earnings Reports
S&P 500
Stock Picks

4 Stocks Morgan Stanley Loves This Earnings Season

As the earnings season heats up, Morgan Stanley is betting on these 4 stocks.

Read More
Daily Perspective
Earnings Reports
S&P 500

The 5 Biggest S&P 500 Movers on Thursday

No. 5: Union Pacific Corp. (UNP) Shares of Union Pacific — which operates the largest railroad system in the U.S. and is one of the world’s largest transportation companies in general — surged 5.9% during Thursday’s session from the previous close of $164.55 to $174.25. With that settlement, UNP stock is now up more than […]

Read More
Medical Devices
One Hot Stock
TradersPro Alerts

Conformis, Inc. (CFMS) Buy Target $3.49 – Sell Target $4.16

Trade Setup Buy Target $3.49 Sell Target $4.16 Trailing Stop 20% Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a customized bicompartmental knee replacement system; and iUni, a […]

Read More
Donald Trump
Fibonacci Retracement
Fundamental Analysis
Health Insurance
HeathCare
Pharmaceuticals
Technical Analysis
Value Investing

Has CVS finally found a bottom?

One of the most underwhelming sectors in this market this year has been Healthcare. As measured by the S&P 500 Healthcare Sector SPDR ETF (XLV), the sector is up just about 6.5% year to date, while the broad market hit a new all-time high earlier and is up a little over 19% since the beginning […]

Read More
Daily Perspective
Earnings Reports
Netflix
Streaming Media

This Earnings Metric Just Single-handedly Tanked Netflix Stock

Shares of Netflix Inc. (NFLX) endured massive double-digit losses after the closing bell Wednesday following the Q2 earnings release. The streaming giant reported some of its worst user numbers in years, leading investors to rake the stock over the coals and drag it toward the lowest levels of 2019.  While most public companies traditionally rely […]

Read More
Alzheimer's
Biopharmaceuticals
One Hot Stock
TradersPro Alerts

vTv Therapeutics Inc. (VTVT) Buy Target $1.52 – Sell Target $1.68

Trade Setup Buy Target $1.52 Sell Target $1.68 Trailing Stop 20% vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops orally administered small molecule drug candidates to fill unmet medical needs. The company is developing Azeliragon, an orally administered, small molecule antagonist targeting the receptor for advanced glycation endproducts, which is in Phase II/III […]

Read More
X